Stewards affiliates report 10M Series B preferred shares
Series B shares carry 50 votes each, and the issuer’s President holds an irrevocable proxy to vote them.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
For Stewards, Inc. (SWRD), affiliate entities report indirect holdings as of September 9, 2026: 22,012,500 common shares, 71,250,000 Series A preferred shares and 10,000,000 Series B preferred shares, the latter held by Forfront Capital, LLC. The preferred shares are not outstanding common stock. The positions also include warrants exercisable for 8,147,368 common shares and pre-funded warrants exercisable for 4,591,000 common shares at $0.0001 per share. Each preferred share is convertible into one common share; Series B conversion is optional after five years from its August 25, 2025 issuance.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series A Preferred Stock F6, F2, F1 | -- | -- | -- |
| holding | Series B Preferred Stock F6, F3, F1 | -- | -- | -- |
| holding | Warrants F4, F1 | -- | -- | -- |
| holding | Pre-Funded Warrants F5, F1 | -- | -- | -- |
| holding | Common Stock, par value $0.0001 per share F1 | -- | -- | -- |
Footnotes (6)
- F1. The securities reported herein are held of record by Forfront Capital, LLC, Stewards Investment Capital Limited ("SIC"), and Stewards International Funds PCC, acting for the Stewards Private Credit Fund. As disclosed in the issuer's Form S-1/A, Glen Steward, Bilal Adam, and Nathaniel Tsang Mang Kin share voting and dispositive power over these securities and may be deemed to beneficially own them. Each disclaims beneficial ownership except to the extent of his pecuniary interest. This report is not an admission of beneficial ownership for Section 16 or any other purpose. Amounts exclude 630,000 common shares held of record by SIC as nominee for Wael Barsoum (part of SIC's 3,442,500 record position). Those shares and related warrants and pre-funded warrants under the same mandate are reported on Mr. Barsoum's separate Form 3. The reporting persons disclaim beneficial ownership of the Barsoum securities.
- F2. Represents 71,250,000 shares of Series A Preferred Stock reported on Table II as a convertible security. Under the Certificate of Designation, as amended, each share is convertible into common stock no sooner than twenty-four (24) months after the Initial Issuance Date (June 5, 2023), at Conversion Amount ($0.25) / Conversion Price ($0.25), or one-for-one. That twenty-four-month period ended June 5, 2025. There is no remaining beneficial-ownership or other conversion cap. These shares are not outstanding common stock and are not reported on Table I.
- F3. Represents 10,000,000 shares of Series B Preferred Stock held of record by Forfront Capital, LLC reported on Table II as a convertible security. Optional conversion into common stock is one-for-one after five years from issuance (August 25, 2025). Each share has 50 votes. Forfront Capital, LLC is party to a Voting Agreement dated August 25, 2025 under which it votes the Series B Preferred Stock at the direction of a majority of the issuer's founders (Glen Steward, Vincent Napolitano, and Shaun Quin), and the issuer's President holds an irrevocable proxy to vote those shares. Forfront Capital, LLC has a pecuniary interest in the Series B Preferred Stock. These shares are not outstanding common stock and are not reported on Table I.
- F4. Represents warrants exercisable for 8,147,368 shares of common stock. The exercise price and the conditions to exercisability and expiration are as set forth in the applicable warrant agreements. Excludes warrants exercisable for 630,000 shares held of record by SIC as nominee for Wael Barsoum.
- F5. Represents pre-funded warrants exercisable for 4,591,000 shares of common stock at an exercise price of $0.0001 per share. Vesting, exercisability and expiration are as set forth in the applicable warrant agreements. Excludes pre-funded warrants exercisable for 9,000 shares held of record by SIC as nominee for Wael Barsoum.
- F6. Each share of Series A Preferred Stock and Series B Preferred Stock is convertible into one share of Common Stock. Each pre-funded warrant is exercisable for one share of Common Stock at $0.0001 per share. Each common warrant is exercisable for one share of Common Stock at the exercise price set forth in the applicable warrant agreement.
Key Figures
Key Terms
convertible security financial
conversion cap financial
pre-funded warrants financial
Voting Agreement regulatory
irrevocable proxy regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which entities hold SWRD’s reported securities?
What is the exercise price of SWRD’s pre-funded warrants?
AI-generated analysis. How Rhea-AI works. Not financial advice.